Highly acclaimed thoracic surgeon Dr. Rodney Landreneau is part of the Pleural & Peritoneal Surface Malignancy Program at Tampa General Hospital Cancer Institute. This unique program provides patients a highly coordinated multidisciplinary care opportunity.
Landreneau has more than 30 years of experience treating patients with esophageal diseases, lung cancer and pleural mesothelioma. Before joining the team at Tampa General Hospital, he was part of The Lung Center at Penn Highlands and served in leadership roles at the University of Pittsburgh Medical Center, Allegheny Health Network and The Gayle and Tom Benson Cancer Center at Ochsner Medical Center in New Orleans.
As a mesothelioma specialist, he built a well-deserved reputation as a medical pioneer, refining the surgical management of pleural mesothelioma. This includes a personalized, multidisciplinary approach to mesothelioma treatment.
Landreneau has experience in both aggressive and minimally invasive thoracic surgery. He handles cases that include esophageal achalasia, esophageal diverticulum, myasthenia gravis and interstitial lung disease.
His clinical interests also include lung cancer molecular biology and brachytherapy management. At Tampa General Hospital, Landreneau works closely with thoracic surgical oncologic surgeons, Dr. K. Eric Sommers, director of thoracic oncology at TGH Cancer institute, and Dr. Jonathan Daniel. TGH Cancer Institute is active in research and is collaborating with the University of Pittsburgh and Baylor College of Medicine in Houston.
Connect with top-rated doctors specializing in mesothelioma treatment, who will personalize treatment options based on your diagnosis.
Find Your DoctorHis late father was a prominent surgeon in Louisiana, where Landreneau grew up. His two brothers (now deceased) also became surgeons and practiced in the state. His sister is a registered nurse still working there.
“Going to Ochsner was the right move for me at the time,” he said. “From a clinical standpoint, and from a family standpoint. It was the right thing to do.”
Landreneau performed surgical debulking coupled with hyperthermic chemotherapy for mesothelioma in 2013, the first in Louisiana history. It was a procedure he had mastered during his earlier days at the University of Pittsburgh Medical Center.
“There had been a large, underserved population in Louisiana for too long,” he shared. “It was a way to help a lot of people from my home area, particularly those with mesothelioma.”
Get answers about treatment, top doctors, and financial support from the nation’s most trusted mesothelioma resource.
Get Your Free Guide
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
Mesothelioma Trust Funds
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Travis Rodgers is an Emmy-nominated journalist with more than two decades of experience in television news. He held many roles in broadcasting, but spent most of his time as a producer crafting live newscasts for multiple network affiliates. Travis now brings his many years of writing experience to Asbestos.com.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
